Elastolytic activity and alveolar epithelial type-1 cell damage after chronic LPS inhalation: Effects of dexamethasone and rolipram

Toxicology and Applied Pharmacology

Volumn 207, Issue 3, 2005, Pages 257-265

  Johnson, Frederick J ^a   Reynolds, Lucy J ^a   Toward, Toby J ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Alveolar type 1 cell; Chronic LPS; Corticosteroid; Elastolytic activity; Neutrophilia; Phosphodiesterase 4 inhibition

Indexed keywords

CONGO RED; CORTICOSTEROID; DEXAMETHASONE; ELASTASE; ELASTIN; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; PHOSPHODIESTERASE IV INHIBITOR; PROTEIN; RAT EPITHELIAL TYPE 1 CELL SPECIFIC GLYCOPROTEIN; ROLIPRAM; UNCLASSIFIED DRUG;

AIRWAY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVITY; CELL DAMAGE; CELL INFILTRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MODEL; DOT HYBRIDIZATION; DRUG EFFECT; ELASTOLYSIS; GUINEA PIG; INFLAMMATORY CELL; INHALATION; LEUKOCYTE; LONG TERM EXPOSURE; LUNG ALVEOLUS CELL TYPE 1; LUNG INJURY; LUNG LAVAGE; MACROPHAGE; MALE; NEUTROPHIL; NEUTROPHILIA; NONHUMAN; PROTECTION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; DEXAMETHASONE; ELASTICITY; EPITHELIAL CELLS; GUINEA PIGS; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; PHOSPHODIESTERASE INHIBITORS; PULMONARY ALVEOLI; ROLIPRAM;

CAVIA; CAVIA PORCELLUS;

EID: 23944443567     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2005.01.006     Document Type: Article

References (44)

1. C. Asti, V. Ruggieri, S. Porzio, R. Chiusaroli, G. Melillo, and G.F. Caselli Lipopolysaccharide-induced lung injury in mice. I. Concomitant evaluation of inflammatory cells and haemorrhagic lung damage Pulm. Pharmacol. Ther. 13 2000 61 69
2. P.J. Barnes Chronic obstructive pulmonary disease: new opportunities for drug development Trends Pharmcol. Sci. 19 1998 415 423
3. P.J. Barnes Inhaled corticosteroids are not beneficial in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 161 2000 342 344
4. P.J. Barnes, and I. Adcock Anti-inflammatory actions of steroids: molecular mechanisms Trends Pharmacol. Sci. 14 1993 436 441
5. P.J. Barnes, K.F. Chung, and C.P. Page Inflammatory mediators of asthma: an update Pharmacol. Rev. 50 1999 515 575
6. K.L. Brigham, and B. Meyrick State of art: endotoxin and lung injury Am. Rev. Respir. Dis. 133 1986 913 927
7. British Thoracic Society Guidelines on the Management of Asthma Thorax 48 1993 S1 S24
8. P.M.A. Calverley Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 161 2000 341 342
9. P.M.A. Calverley, and N.B. Pride Chronic obstructive pulmonary disease 1995 Chapman and Hall Medical Press London 3 5
10. M. Corbel, N. Germain, J. Lanchou, S. Molet, P.M. R e Silva, M.A. Martens, E. Boichot, and V. Lagente The selective phosphodiesterase 4 inhibitor RP 73-401 reduced matrix metalloproteinase 9 activity and transforming growth factor-beta release during acute lung injury in mice: the role of the balance between tumor necrosis factor-alpha and interleukin-10 J. Pharmacol. Exp. Ther. 301 2002 258 265
11. L.G. Dobbs, M.C. Williams, and R. Gonzalez Monoclonal antibodies specific to apical surfaces of rat alveolar type-1 cells bind to the surfaces of cultured, but not freshly isolated type II cells Biochem. Biophys. Acta 970 1988 146 156
12. W.W. Fleischhacker, H. Hinterhuber, H. Bauer, B. Pflug, C. Simhandl, R. Wolf, W. Gerlach, H. Jaklitsch, and M. Sastre-y-Hernandez A multicenter double-blind study of three doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder Neuropsychobioology 26 1992 59 64
13. G. Folkerts, and F.P. Nijkamp Airway epithelium: more than just a barrier! Trends Pharmacol. Sci. 19 1998 334 341
14. E. Gamble, D.C. Grootendorst, C.E. Brightling, S. Troy, Y. Qui, J. Zhu, D. Parker, M.A. Vignola, C. Kroegel, F. Morell, T.T. Hansel, S.I. Rennard, C. Compton, A. Ohad, T. Tri, J. Edelson, I.D. Pavord, K.F. Rabe, N.C. Barnes, and P.K. Jeffery Anti-inflammatory effects of the phosphodiesterase 4 inhibitor cilomast (Ariflo) in COPD Am. J. Respir. Crit. Care Med. 168 2003 976 982
15. B. Hughes, D. Howat, M. Lisle, M. Holbrook, T. James, N. Gozzard, K. Blease, P. Hughes, R. Kingaby, G. Warrellow, R. Alexander, J. Head, E. Boyd, M. Eaton, M. Perry, M. Wales, B. Smith, R. Owens, C. Catterall, S. Lumb, A. Russell, R. Allen, M. Merriman, D. Bloxham, and G. Higgs The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4 Br. J. Pharmacol. 118 1996 1183 1191
16. A. Jackson Airway goblet-cell mucus secretion Trends Pharmacol. Sci. 2 2001 39 45
17. K. Kawabata, T. Hagio, S. Matsumoto, S. Nakao, S. Orita, Y. Aze, and H. Ohmno Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters Am. J. Repir. Crit. Care Med. 161 2000 2013 2018
18. H. Li, G. He, H. Chu, L. Zhao, and H. Yu A step-wise application of methylprednisolone versus dexamethasone in the treatment of acute exacerbations of COPD Respirology 8 2003 199 204
19. M.C. McElroy, and M. Kasper The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair Eur. Respir. J. 24 2004 664 673
20. M.C. McElroy, J.F. Pittet, L. Allen, J.P. Wiener-Kronish, and L.G. Dobbs Biochemical detection of type-1 cell damage after nitrogen dioxide-induced lung injury in rats Am. J. Physiol. 273 1997 L1228 L1234
21. M.C. McElroy, J.-F. Pittet, S. Hashimoto, L. Allen, J.P. Wiener-Kronish, and L.G. Dobbs A type-1 cell specific protein is a biomedical marker of epithelial injury in a rat model of pneumonia Am. J. Physiol. 268 1997 L181 L186
22. T. Matsuda, M.M. Onda, M. Miyashita, and N. Matsuda Endotoxin-induced lung injury. The role of leukocytes, oxidants and the efficacy of steroids and antioxidants Nippon Ika Daigaku Zasshi 62 1995 150 156
23. H. Motulsky Intuitive biostatistics 1995 Oxford Univ. Press New York 258 259
24. K. Nishina, K. Mikawa, Y. takao, N. Maekawa, M. Shiga, and H. Obara ONO-5046, an elastase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits Anesth. Analg. 84 1997 1097 1103
25. P.D. Pare, and J.C. Hogg Mechanics of airway narrowing Am. Rev. Respir. Dis. 139 1989 242 246
26. D.S. Postma, and H.A.M. Kerstjens Characteristics of airway hyperresponsiveness in asthma and chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 158 1998 S187 S192
27. L.J. Reynolds, M. McElroy, and R.J. Richards Density and substrata are important in lung type II cell differentiation in vitro Int. J. Biochem. Cell Biol. 31 1999 951 960
28. R.E. Russell, A. Thorley, S.V. Culpitt, S. Dodd, L.E. Donnelly, M. Fitzgerald, and P.J. Barnes Alveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteases Am. J. Physiol.: Lung Cell. Mol. Physiol. 283 2002 L867 L873
29. F. Sakamaki, A. Ishizaka, T. Urano, K. Sayama, H. Nakamura, T. Terashima, Y. Waki, S. Tasaka, N. Hasegawa, K. Sato, N. Nakagawa, T. Obata, and M. Kanazawa Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin-induced acute lung injury Am. J. Respir. Crit. Care Med. 153 1996 391 397
30. J.D. Savov, D.M. Brass, G. Berman, E. McElvania, and D.A. Schwartz Fibrinolysis in LPS-induced chronic airways disease Am. J. Physiol.: Lung Cell Mol. Physiol. 285 2003 L940 L948
31. L.D. Sekut, S.A. Yarnall, L.S. Stimpson, R. Noel, R.L. Bateman-Fite, M.F. Brackeen, J.A. Menius, and K.M. Connolly Anti-inflammatory activity of phosphodiesterase (PDE)-IV inhibitors in acute and chronic models of inflammation Clin. Exp. Immunol. 100 1995 126 132
32. M.C. Snella, and R. Rylander Endotoxin inhalation induces neutrophil chemotaxis by alveolar macrophages Agents Actions 16 1985 521 526
33. R.A. Stockley Neutrophils and the pathogenesis of COPD Chest 121 2002 151S 155S
34. J. Stolk, A. Rudolphus, P. Davies, D. Osinga, J.H. Dijkman, L. Agarwal, K.P. Keenan, D. Fletcher, and J.A. Kramps Induction of emphysema and bronchial mucus cell hyperplasia by intratracheal installations of lipopolysaccharide in the hamster J. Pathol. 167 1992 349 356
35. Z.E. Suntres, and P.N. Shek Prophylaxis against lipopolysaccharide- induced lung injuries by liposome-entrapped dexamethasone in rats Biochem. Pharmacol. 59 2000 1155 1161
36. T.J. Torphy, M.S. Barnette, D.C. Underwood, D.E. Griswold, S.B. Christensen, R.D. Murdoch, R.B. Nieman, and C.H. Compton Ariflo (SB 207499), a second generation phosphodiesterase 4 inhibitor for the treatment of asthma and COPD: from concept to clinic Pulm. Pharmacol. Ther. 12 1999 131 135
37. T.J. Toward, and K.J. Broadley Airway reactivity, inflammatory cell influx and nitric oxide in guinea-pig airways after lipopolysaccharide inhalation Br. J. Pharmacol. 131 2000 271 281
38. T.J. Toward, and K.J. Broadley Chronic lipopolysaccharide exposure on airway function, cell infiltration and nitric oxide generation in conscious guinea-pigs: effect of rolipram and dexamethasone J. Pharmacol. Exp. Ther. 298 2001 298 306
39. T.J. Toward, and K.J. Broadley Goblet cells hyperplasia, airway function, and leukocyte infiltration after chronic lipopolysaccharide exposure in conscious guinea-pigs: effects of rolipram and dexamethasone J. Pharmacol. Exp. Ther. 302 2002 814 821
40. T.J. Toward, and K.J. Broadley Airway function, oedema, cell infiltration and nitric oxide generation in conscious ozone-exposed guinea-pigs: effects of dexamethasone and rolipram Br. J. Pharmacol. 136 2002 735 745
41. A. Van de Louw, D. Jean, E. Frisdal, C. Cerf, M.P. d'Ortho, A.H. Baker, C. Lafuma, P. Duvaldestin, A. Harf, and C. Delclaux Neutrophil proteinases in hydrochloric acid- and endotoxin-induced acute lung injury: evaluation of interstitial protease activity by in situ zymography Lab. Invest. 82 2002 133 145
42. J.H. Vernooy, M.A. Dentener, R.J. van Suylen, W.A. Buurman, and E.F. Wouters Long-term intratracheal lipopolysaccharide exposure in mice results in chronic lung inflammation and persistent pathology Am. J. Respir. Cell Mol. Biol. 26 2002 152 159
43. R.L. Warner, N. Bhagavathula, K.C. Nerusu, H. Lateef, E. Younkin, K.J. Johnson, and J. Varani Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro Exp. Mol. Pathol. 76 2004 189 195
44. C.J. Whelan, S.C. Hughes, and G.P. Wren Inhibition of some aspects of acute inflammation of guinea-pig lung by intraperitoneal dexamethasone and mifepristone: demonstration of agonist activity of mifepristone in the guinea-pig Inflammation Res. 44 1995 131 138